Fri, 20 Oct 2017 09:05:55 GMT
Imprimis Pharma shares jump on eye drug cheaper alternative
On Thursday, Imprimis Pharma shares skyrocketed 91%, following the company's announcement about launch of the cheaper alternative Restasis to Allergan's eye drug by next month.